Rapid identification of the predominant azole-resistant genotype in Candida tropicalis

FEMS Yeast Res. 2024 Jan 9:24:foae025. doi: 10.1093/femsyr/foae025.

Abstract

Candida tropicalis is a leading cause of nonalbicans candidemia in tropical/subtropical areas and a predominant genotype of azole-resistant C. tropicalis clinical isolates belongs to clade 4. The aim of this study was to reveal markers for rapidly identifying the predominant azole-resistant C. tropicalis genotype. We analysed XYR1, one of the six genes used in the multilocus sequence typing analysis, and SNQ2, an ATP-binding cassette transporter in 281 C. tropicalis, including 120 and 161 from Taiwan and global areas, respectively. Intriguingly, the first 4-mer of codon sequences ATRA of CTRG_05978 (96/119 versus 21/162, P < .001, at phi = 0. 679) and the SNQ2 A2977G resulting in amino acid I993V alternation (105/118 versus 12/163, P < .001, at phi = 0.81) was significantly associated with the clade 4 genotype. The sensitivity and specificity of the clade 4 genotype detection with a combination of SNPs of CTRG_05978 and SNQ2 were 0.812 and 0.994, respectively, at phi = 0.838. Furthermore, we successfully established a TaqMan SNP genotyping assay to identify the clade 4 genotype. Our findings suggest that to improve the management of C. tropicalis infections, rapidly identifying azole-resistant C. tropicalis by detecting SNPs of CTRG_05978 and SNQ2 is promising.

Keywords: Candida tropicalis; SNQ2; XYR1; MLST; xylose reductase.

Publication types

  • Evaluation Study

MeSH terms

  • Antifungal Agents* / pharmacology
  • Azoles* / pharmacology
  • Candida tropicalis* / drug effects
  • Candida tropicalis* / genetics
  • Candida tropicalis* / isolation & purification
  • Drug Resistance, Fungal* / genetics
  • Genotype*
  • Humans
  • Polymorphism, Single Nucleotide
  • Sensitivity and Specificity
  • Taiwan

Substances

  • Azoles
  • Antifungal Agents